Egypt Drug Authority: BE study conduct [Design Issues]

posted by Debbie – India, 2014-12-23 08:13 (3411 d 07:37 ago) – Posting: # 14148
Views: 3,522

Dear Sir,

As a CRO professional, we have received the studies for Egypt market. For that we would like to know about the conduct of Bioequivalence study.

Whether is it mandatory to conduct the bio-equivalence study in Egyptian population to meet the requirements of EDA (Egypt Drug Authority) or EDA (Egypt Drug Authority) will accept the bio-equivalence study conducted in compliance to the requirements of EDA (Egypt Drug Authority) in any other country population (Other than Egypt).

In listed EDA guidelines on the Bioequivalence study are not detailed about this.

Please respond the mail and advise me to take necessary steps for the conduct of the BE study.

Thanks & Regards,
Santhosh Kumar B


Edit: Category changed and subject line changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,653 registered users;
114 visitors (0 registered, 114 guests [including 6 identified bots]).
Forum time: 16:51 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5